title: Willingness to use HIV pre-exposure prophylaxis among opiate users.
abstract: Few studies of pre-exposure prophylaxis (PrEP) to prevent HIV infection have focused on drug users. Between February to September 2013, we asked 351 opiate injectors entering detoxification treatment about HIV risk, knowledge about PrEP, and willingness to use a once daily PrEP pill under one of two randomly assigned effectiveness scenarios-40 % (low) or 90 % (high) effective in reducing HIV risk. Participants were 70 % male and 87 % non-Hispanic White. Only 7 % had heard of a drug to reduce HIV risk, yet once informed, 47 % would be willing to take such a pill [35 % of those in the low effectiveness scenario and 58 % in the high group (p < 0.001)]. Higher perceived HIV risk was associated with greater willingness to take medication. Increasing knowledge of PrEP and the rate of HIV reduction-effectiveness promised will influence its use among targeted high-risk drug users.
authors.affiliation: General Medicine Research Unit, Butler Hospital, Alpert School of Medicine at Brown University, 345 Blackstone Blvd, Providence, RI, 02906, USA, mstein@butler.org.
authors.forename: Michael
authors.initials: M
authors.lastname: Stein
authors.forename: Portia
authors.initials: P
authors.lastname: Thurmond
authors.forename: Genie
authors.initials: G
authors.lastname: Bailey
mesh_terms: D000284:Administration, Oral; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control* / Q000821:virology; D007722:Health Knowledge, Attitudes, Practice; D006306:Health Surveys; D006801:Humans; D008297:Male; D008404:Massachusetts; D009293:Opioid-Related Disorders / Q000150:complications* / Q000628:therapy; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*; D012307:Risk Factors; D012959:Socioeconomic Factors; D016320:Substance Abuse Treatment Centers; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000628:therapy; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents
references.citation: Drug Alcohol Depend. 1997 Jan 10;44(1):47-55
references.pmid: 9031820
references.citation: Sex Transm Infect. 2011 Jun;87(4):344-8
references.pmid: 21357600
references.citation: AIDS Patient Care STDS. 2011 Jun;25(6):365-70
references.pmid: 21470046
references.citation: PLoS One. 2011;6(8):e17502
references.pmid: 21826193
references.citation: Curr Opin HIV AIDS. 2012 Nov;7(6):563-8
references.pmid: 23076122
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8
references.pmid: 21270743
references.citation: AIDS Educ Prev. 2012 Oct;24(5):408-21
references.pmid: 23016502
references.citation: Lancet. 2013 Jun 15;381(9883):2083-90
references.pmid: 23769234
references.citation: JAMA. 2008 Aug 6;300(5):520-9
references.pmid: 18677024
references.citation: MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):463-5
references.pmid: 23760186
references.citation: J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S95-101
references.pmid: 23673895
references.citation: N Engl J Med. 2012 Aug 2;367(5):423-34
references.pmid: 22784038
references.citation: Public Health Rep. 1998 Jun;113 Suppl 1:75-80
references.pmid: 9722812
references.citation: J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):241-7
references.pmid: 18340656
references.citation: AIDS Care. 2002 Feb;14(1):77-93
references.pmid: 11798407
references.citation: J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):354-9
references.pmid: 22267017
references.citation: AIDS Patient Care STDS. 2010 Nov;24(11):689-91
references.pmid: 20863247
references.citation: AIDS Care. 2011 Sep;23(9):1136-45
references.pmid: 21476147
references.citation: N Engl J Med. 2012 Aug 2;367(5):411-22
references.pmid: 22784040
references.citation: N Engl J Med. 2010 Dec 30;363(27):2587-99
references.pmid: 21091279
references.citation: J Subst Abuse. 1993;5(2):187-93
references.pmid: 8104569
references.citation: J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83
references.pmid: 19295337
references.citation: J Urban Health. 2003 Dec;80(4 Suppl 3):iii59-66
references.pmid: 14713672
references.citation: AIDS Behav. 2010 Aug;14(4):731-47
references.pmid: 19020970
references.citation: J Acquir Immune Defic Syndr. 2010 Oct;55(2):e14-6
references.pmid: 20859085
references.citation: N Engl J Med. 2012 Aug 2;367(5):399-410
references.pmid: 22784037
references.citation: J Acquir Immune Defic Syndr. 2010 Aug;54(5):548-55
references.pmid: 20512046
references.citation: Health Psychol. 1995 May;14(3):255-64
references.pmid: 7641667
references.citation: Sex Transm Infect. 2013 May;89(3):207-11
references.pmid: 23015689
references.citation: Public Health Rep. 1998 Jun;113 Suppl 1:19-30
references.pmid: 9722807